Table 3 Fixed effect estimates indicating mean %-differences between 78 VLBW adults and 72 sibling controls born at term, adjusted for covariates.
Effect estimate (%) | 95% CI lower limit (%) | 95% CI upper limit (%) | |
|---|---|---|---|
Abdominal adipose tissue** | |||
Model 1 | − 3.44 | − 15.83 | 10.76 |
Model 2 | 1.05 | − 13.72 | 18.36 |
Model 3 | − 1.11 | − 8.69 | 7.10 |
Subcutaneous adipose tissue** | |||
Model 1 | − 4.72 | − 16.67 | 8.96 |
Model 2 | − 0.48 | − 14.80 | 16.26 |
Model 3 | − 2.67 | − 9.50 | 4.68 |
Visceral adipose tissue** | |||
Model 1 | 1.63 | − 13.90 | 19.96 |
Model 2 | 7.96 | − 10.44 | 30.14 |
Model 3 | 6.68 | − 6.62 | 21.87 |
Hepatic triglyceride content (n = 77 + 71) | |||
Model 1 | 4.94 | − 22.21 | 41.58 |
Model 2 | 12.05 | − 20.16 | 57.26 |
Model 3 | 5.61 | − 20.95 | 41.08 |
Subcutaneous fat double bond ratio (n = 77 + 72) | |||
Model 1 | − 3.69 | − 7.82 | 0.62 |
Model 2 | − 4.74* | − 9.19 | − 0.08 |
Model 3 | − 4.79* | − 9.22 | − 0.14 |
Bone marrow double bond ratio (n = 65 + 60) | |||
Model 1 | 0.16 | − 2.96 | 3.38 |
Model 2 | 1.68 | − 1.86 | 5.35 |
Model 3 | 1.76 | − 1.78 | 5.42 |